Dr. Lal Path Labs Ltd.

Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹1687.40
Market cap
28,281 Cr
Stock P/E
60.5
P/B
11.13
Dividend yield
0.8%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales541 Cr1,142 Cr1,681 Cr2,227 Cr602 Cr1,262 Cr597 Cr603 Cr670 Cr731 Cr660 Cr703 Cr
Operating expenses (approx.)380 Cr786 Cr1,166 Cr1,548 Cr411 Cr847 Cr418 Cr408 Cr449 Cr482 Cr486 Cr492 Cr
EBITDA161 Cr357 Cr515 Cr679 Cr191 Cr415 Cr179 Cr195 Cr220 Cr249 Cr174 Cr211 Cr
OPM %29.7%31.2%30.7%30.5%31.7%32.9%30.0%32.3%32.9%34.1%26.3%30.0%
Other income14 Cr33 Cr51 Cr69 Cr21 Cr43 Cr25 Cr26 Cr28 Cr25 Cr24 Cr24 Cr
Interest8 Cr16 Cr23 Cr29 Cr6 Cr12 Cr5 Cr5 Cr5 Cr5 Cr7 Cr6 Cr
Depreciation35 Cr71 Cr107 Cr144 Cr35 Cr70 Cr36 Cr36 Cr35 Cr41 Cr42 Cr45 Cr
Profit before tax118 Cr270 Cr386 Cr506 Cr150 Cr333 Cr138 Cr153 Cr181 Cr204 Cr124 Cr160 Cr
Tax %28.9%28.0%28.3%28.3%28.1%28.3%29.1%-1.4%26.0%25.2%26.5%17.4%
Net profit84 Cr194 Cr277 Cr362 Cr108 Cr239 Cr98 Cr156 Cr134 Cr152 Cr91 Cr132 Cr
EPS (₹)₹9.95₹23.11₹32.88₹43.05₹12.79₹28.30₹11.60₹18.57₹15.88₹18.05₹5.42₹7.86

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,203 Cr1,330 Cr1,581 Cr2,087 Cr2,017 Cr2,227 Cr2,461 Cr2,763 CrSign in for TTM
Operating expenses (approx.)864 Cr932 Cr1,094 Cr1,474 Cr1,527 Cr1,617 Cr1,673 Cr1,909 CrSign in for TTM
EBITDA340 Cr399 Cr488 Cr613 Cr490 Cr609 Cr789 Cr854 CrSign in for TTM
OPM %28.2%30.0%30.8%29.4%24.3%27.4%32.1%30.9%Sign in for TTM
Other income46 Cr55 Cr51 Cr53 Cr42 Cr69 Cr93 Cr101 CrSign in for TTM
Interest0.80 Cr15 Cr16 Cr30 Cr38 Cr29 Cr22 Cr23 CrSign in for TTM
Depreciation38 Cr73 Cr77 Cr108 Cr150 Cr144 Cr142 Cr162 CrSign in for TTM
Profit before tax301 Cr311 Cr394 Cr475 Cr344 Cr506 Cr625 Cr669 CrSign in for TTM
Tax %33.3%26.7%24.8%26.2%29.9%28.3%21.2%23.8%Sign in for TTM
Net profit201 Cr228 Cr297 Cr350 Cr241 Cr362 Cr492 Cr510 CrSign in for TTM
EPS (₹)₹24.19₹27.42₹35.33₹41.70₹28.82₹43.05₹58.48₹30.24Sign in for TTM
Dividend payout %———33.3%42.7%55.5%42.1%43.7%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Equity capital83 Cr83 Cr83 Cr83 Cr83 Cr84 Cr84 Cr168 Cr
Reserves0.0000 Cr0.0000 Cr1,162 Cr1,425 Cr1,583 Cr1,766 Cr2,089 Cr2,341 Cr
Borrowings———346 Cr237 Cr83 Cr——
Other liabilities136 Cr302 Cr356 Cr392 Cr449 Cr487 Cr510 Cr605 Cr
Total liabilities1,067 Cr1,318 Cr1,573 Cr2,214 Cr2,386 Cr2,456 Cr2,717 Cr3,146 Cr
Fixed assets (net)151 Cr277 Cr283 Cr351 Cr401 Cr343 Cr336 Cr484 Cr
CWIP3 Cr10 Cr6 Cr14 Cr3 Cr4 Cr4 Cr6 Cr
Investments214 Cr253 Cr171 Cr1,069 Cr150 Cr114 Cr327 Cr423 Cr
Other assets797 Cr863 Cr1,111 Cr715 Cr974 Cr1,128 Cr1,365 Cr1,568 Cr
Total assets1,067 Cr1,318 Cr1,573 Cr2,214 Cr2,386 Cr2,456 Cr2,717 Cr3,146 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———447 Cr456 Cr535 Cr569 Cr636 Cr
Cash from investing———-449 Cr-287 Cr-24 Cr-303 Cr-422 Cr
Cash from financing———136 Cr-283 Cr-414 Cr-334 Cr-264 Cr
Net cash flow———134 Cr-114 Cr97 Cr-68 Cr-50 Cr
Free cash flow (OCF − Capex)———353 Cr420 Cr484 Cr525 Cr469 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019Standalone onlyMar 2020Standalone onlyMar 2021Standalone onlyMar 2022Standalone onlyMar 2023Mar 2024Mar 2025Mar 2026
ROCE %361.8%391.1%33.0%33.5%17.5%23.7%29.3%27.2%
ROE %0.0%0.0%23.4%22.9%14.1%19.0%22.1%19.9%
Debtor days171416131313——
Inventory days4070383228302730
Days payable110143132101127151——
Cash conversion cycle-54-59-79-55-87-1082730
Debt / equity—0.00—0.230.140.05——
Current ratio5.924.084.401.592.072.423.393.48
Net debt / EBITDA0.000.000.000.00-0.06-0.46-0.37-0.28

Compare with peers

Loading peers…